Opendata, web and dolomites

OR-HMC

Assay for cancer diagnostics by quantification of 5hmC

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

Project "OR-HMC" data sheet

The following table provides information about the project.

Coordinator
TEL AVIV UNIVERSITY 

Organization address
address: RAMAT AVIV
city: TEL AVIV
postcode: 69978
website: http://www.tau.ac.il/

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Israel [IL]
 Total cost 150˙000 €
 EC max contribution 150˙000 € (100%)
 Programme 1. H2020-EU.1.1. (EXCELLENT SCIENCE - European Research Council (ERC))
 Code Call ERC-2017-PoC
 Funding Scheme ERC-POC
 Starting year 2017
 Duration (year-month-day) from 2017-08-01   to  2019-01-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    TEL AVIV UNIVERSITY IL (TEL AVIV) coordinator 150˙000.00

Map

 Project objective

Assay for cancer diagnostics by quantification of 5hmC

5-hydroxymethylcytosine (5hmC) is a modified form of the DNA base cytosine and is an important epigenetic marker linked to regulation of gene expression in development and tumorigenesis. The loss of 5hmC is observed across a wide spectrum of malignant tumours. The goal of the proposed project is to utilize a novel chemo-enzymatic labelling scheme developed within the framework of my ERC project in order to develop a high-throughput assay capable of quantifying 5hmC levels for cancer diagnostics. We have developed a spectroscopic method for global quantification of 5hmC in genomic DNA, which can be performed in multi-well plates for high throughput analysis, or on individual DNA molecules for ultimate sensitivity. We aim to combine these two approaches and further develop a simple and rapid multi-well slide assay which measures 5hmC levels in DNA, and combines both high throughput and high sensitivity. This slide will be compatible with a standard microarray scanner, lowering the development barriers for commercialisation of specific diagnostic applications. In parallel, we aim to establish the relationship between 5hmC levels in colorectal cancer and the state of disease. Preliminary results show significant decrease of 5hmC in colorectal cancer samples relative to that of healthy colon. This assay will potentially offer earlier diagnosis of cancer as well as means for easy monitoring of disease and response to treatment. The project aims to establish preliminary analysis of colorectal cancer samples but the general approach may be directly extended to other types of malignancies.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "OR-HMC" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "OR-HMC" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.1.)

QUBE (2019)

Quantum technology with carbon nanotUBEs

Read More  

DEEPTIME (2020)

Probing the history of matter in deep time

Read More  

CONTROL (2019)

Laser control over crystal nucleation

Read More